Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 61, Issue 23, Pages 2954-2964Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-004-4276-8
Keywords
thyroid; tyrosine kinase inhibitors; RET; MEN2; papillary thyroid carcinoma
Categories
Ask authors/readers for more resources
RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a single gene that causes different types of human cancer when targeted by different genetic alterations. Like other receptor tyrosine kinases, once activated, RET recruits a variety of signaling molecules that mediate biological responses. Here we review data on the signaling pathways that lead to RET-mediated cell transformation and recent evidence that manipulation of RET holds promise for thyroid cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available